Molecular Templates to Host Webinar on a Unique Approach to Immuno-Oncology for Solid Tumors Apr 08, 2022 8:00am EDT
Molecular Templates, Inc. Announces Fast Track Designation Granted by FDA for MT-6402 Nov 18, 2021 8:00am EST
Molecular Templates to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit Sep 20, 2021 8:00am EDT
Molecular Templates, Inc. Announces Dosing of First Subject in Phase 1 Study of MT-6402 in PD-L1-Positive Solid Tumors Jul 09, 2021 8:00am EDT
